Skip to main content
. 2021 Sep 25;15(2):371–383. doi: 10.1111/cts.13154

FIGURE 3.

FIGURE 3

Antidepressants considered for pharmacogenetic guidance. More than one response was allowed. Only 16 of 17 sites responded. Providers may have access to the PGx report and use it to tailor additional psychotropic medications. CPIC, Clinical Pharmacogenetics Implementation Consortium; PGx, pharmacogenetic, TCA, tricyclic antidepressants